Kelley Conte - 01 Jun 2023 Form 4 Insider Report for ASPEN AEROGELS INC (ASPN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jun 2023, 16:00:56 UTC
Prior SEC filing
28 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Virginia H. Johnson, Attorney-in-Fact

Key filing fact

Kelley Conte filed Form 4 for ASPEN AEROGELS INC (ASPN) on 02 Jun 2023.

Key facts

  • This page summarizes Kelley Conte's Form 4 filing for ASPEN AEROGELS INC (ASPN).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Jun 2023, 16:00.

Change

  • Previous filing in this sequence was filed on 28 Feb 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASPN transaction

Common Stock

Award

Transaction value
$0
Shares
+14,684
Change %
+13%
Price
$0.000000
Shares after
128,183
Date
01 Jun 2023
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASPN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+67,537
Change %
Price
$0.000000
Shares after
67,537
Date
01 Jun 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
67,537
Exercise price
$6.81
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents the right to receive one share of Common Stock upon vesting. The RSUs vest as to one-third of the shares on March 8, 2024, an additional one-third of the shares on March 8, 2025 and the remaining one-third of the shares on March 8, 2026.

Footnote F2

Represents 56,424 shares of Common Stock, 18,169 RSUs and 53,590 shares of Restricted Stock.

Footnote F3

The options vest as to one-third of the shares on March 8, 2024, an additional one-third of the shares on March 8, 2025 and the remaining one-third of the shares on March 8, 2026.

SEC remarks

Power of Attorney is attached hereto as Exhibit 24.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .